Current and historical revenue for Pfizer (PFE) from 2006 to 2018. Revenue can be defined as the sum of all revenue fields included for a company's operating activities. Pfizer revenue for the twelve months ending June 30, 2018 was $53.243B. Pfizer revenue for the three months ending June 30, 2018 was $13.466B, representing a 4.42% increase from the same quarter last year.
Pfizer Annual Revenue
(Millions of US $) |
| 2017 |
$52,546 |
| 2016 |
$52,824 |
| 2015 |
$48,851 |
| 2014 |
$49,605 |
| 2013 |
$51,584 |
| 2012 |
$54,657 |
| 2011 |
$61,035 |
| 2010 |
$65,165 |
| 2009 |
$49,269 |
| 2008 |
$48,296 |
| 2007 |
$48,418 |
| 2006 |
$48,371 |
| 2005 |
$47,405 |
Pfizer Quarterly Revenue
(Millions of US $) |
| Q2 2018 |
$13,466 |
| Q1 2018 |
$12,906 |
| Q4 2017 |
$13,703 |
| Q3 2017 |
$13,168 |
| Q2 2017 |
$12,896 |
| Q1 2017 |
$12,779 |
| Q4 2016 |
$13,627 |
| Q3 2016 |
$13,045 |
| Q2 2016 |
$13,147 |
| Q1 2016 |
$13,005 |
| Q4 2015 |
$14,047 |
| Q3 2015 |
$12,087 |
| Q2 2015 |
$11,853 |
| Q1 2015 |
$10,864 |
| Q4 2014 |
$13,118 |
| Q3 2014 |
$12,361 |
| Q2 2014 |
$12,773 |
| Q1 2014 |
$11,353 |
| Q4 2013 |
$13,558 |
| Q3 2013 |
$12,643 |
| Q2 2013 |
$12,973 |
| Q1 2013 |
$12,410 |
| Q4 2012 |
$12,851 |
| Q3 2012 |
$12,953 |
| Q2 2012 |
$13,968 |
| Q1 2012 |
$14,885 |
| Q4 2011 |
$11,439 |
| Q3 2011 |
$16,609 |
| Q2 2011 |
$16,485 |
| Q1 2011 |
$16,502 |
| Q4 2010 |
$15,462 |
| Q3 2010 |
$15,995 |
| Q2 2010 |
$17,132 |
| Q1 2010 |
$16,576 |
| Q4 2009 |
$15,797 |
| Q3 2009 |
$11,621 |
| Q2 2009 |
$10,984 |
| Q1 2009 |
$10,867 |
| Q4 2008 |
$12,346 |
| Q3 2008 |
$11,973 |
| Q2 2008 |
$12,129 |
| Q1 2008 |
$11,848 |
| Q4 2007 |
$12,870 |
| Q3 2007 |
$11,990 |
| Q2 2007 |
$11,084 |
| Q1 2007 |
$12,474 |
| Q4 2006 |
$12,603 |
| Q3 2006 |
$12,280 |
| Q2 2006 |
$11,741 |
| Q1 2006 |
$11,747 |
| Q4 2005 |
$11,599 |
| Q3 2005 |
$11,263 |
| Q2 2005 |
$11,452 |
| Q1 2005 |
$13,091 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$245.020B |
$52.546B |
|
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
|
